Biocon Limited (NSE:BIOCON)
420.30
+4.25 (1.02%)
Jun 16, 2026, 9:35 AM IST
Biocon Market Cap
Biocon has a market cap or net worth of 673.32 billion as of June 15, 2026. Its market cap has increased by 67.92% in one year.
Market Cap
673.32B
Enterprise Value
814.73B
Revenue
169.27B
Ranking
n/a
PE Ratio
147.54
Stock Price
420.30
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 673.32B, an increase of 1,382.67%. That is a compound annual growth rate of 12.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 673.32B | 28.09% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anthem Biosciences | 442.94B |
| OneSource Specialty Pharma | 184.87B |
| Concord Biotech | 141.63B |
| Blue Jet Healthcare | 88.90B |
| Supriya Lifescience | 78.64B |
| Zota Health Care | 42.43B |
| Panacea Biotec | 32.83B |
| Dishman Carbogen Amcis | 28.95B |